EcoDrugPlus

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSORLG00000013932
Gene Symbol: SLC6A4A
4 Cross references
201 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSORLG00000012525
Gene Symbol: SLC6A9
4 Cross references
208 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSORLG00000009128
Gene Symbol: SLC9A3
4 Cross references
234 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSORLG00000007973
Gene Symbol: SSTR2
4 Cross references
192 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSORLG00000026702
Gene Symbol: SSTR4
1 Cross references
206 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSORLG00000001415
Gene Symbol: SSTR5
1 Cross references
188 Possible Orthologues:

Somatostatin Receptor Type 5

Ensembl ID : ENSORLG00000010790
Gene Symbol: LOC101163302
3 Cross references
183 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSORLG00000024922
Gene Symbol: SPHK2
3 Cross references
200 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSORLG00000014096
Gene Symbol: S1PR1
4 Cross references
200 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSORLG00000014520
Gene Symbol: SYK
4 Cross references
200 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSORLG00000024527
Gene Symbol: SRD5A2B
4 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSORLG00000017233
Gene Symbol: SOAT1
4 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).